World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
149
Citations
118066
World Ranking
1176
National Ranking
683

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Harald Hampel is affiliated with Eisai in the United States and has made significant contributions primarily within the fields of medicine and neuroscience. Their work emphasizes research related to Alzheimer's disease and related neurodegenerative conditions.

The scientist's publication record includes a variety of influential papers, with key recent works including:

  • The Amyloid-β Pathway in Alzheimer's Disease, 2021, Molecular Psychiatry
  • The β-Secretase BACE1 in Alzheimer's Disease, 2020, Biological Psychiatry
  • A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease, 2020, Frontiers in Immunology
  • Exercise benefits on Alzheimer's disease: State-of-the-science, 2020, Ageing Research Reviews
  • Developing the ATX(N) classification for use across the Alzheimer disease continuum, 2021, Nature Reviews Neurology

Their frequent co-authors include:

  • Andrea Vergallo
  • Simone Lista
  • Bruno Dubois
  • Filippo Baldacci
  • Pablo Lemercier

Harald Hampel often publishes in the following venues:

  • Alzheimer s & Dementia
  • Neurobiology of Aging
  • Alzheimer s Research & Therapy
  • Ageing Research Reviews
  • The Journal of Prevention of Alzheimer s Disease

Their research covers various subfields of study including physiology, psychiatry and mental health, cognitive neuroscience, neurology, and molecular biology. Major topics of focus include:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Functional Brain Connectivity Studies
  • EEG and Brain-Computer Interfaces
  • Health Systems, Economic Evaluations, Quality of Life
  • Cholinesterase and Neurodegenerative Diseases
  • Neuroinflammation and Neurodegeneration Mechanisms

Best Publications

  • Inflammation and Alzheimer's disease.

    H Akiyama;S Barger;S Barnum;B Bradt

  • Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj

  • Mild cognitive impairment

    Serge Gauthier;Barry Reisberg;Michael Zaudig;Ronald C. Petersen

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel

  • Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

    Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims

  • Variant of TREM2 associated with the risk of Alzheimer's disease

    Thorlakur Jonsson;Hreinn Stefansson;Stacy Steinberg;Ingileif Jonsdottir

  • Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics (2009) 41 (1088-1093))

    D Harold;R Abraham;P Hollingworth;R Sims

  • Revising the definition of Alzheimer's disease: a new lexicon.

    Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

    Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish

  • Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

    Kaj Blennow;Harald Hampel;Michael Weiner;Henrik Zetterberg

  • Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

    Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens

  • Analysis of shared heritability in common disorders of the brain

    Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters

  • A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

    Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo

  • The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

    Harald Hampel;M.-Marsel Mesulam;A Claudio Cuello;Martin R Farlow

  • Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

    Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  • CSF markers for incipient Alzheimer's disease

    Kaj Blennow;Harald Hampel

  • The Amyloid-β Pathway in Alzheimer's Disease.

    Harald Hampel;John Hardy;Kaj Blennow;Kaj Blennow;Christopher Chen

  • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

    Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen

  • Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

    Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi

  • Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimertextquotesingles disease

    Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims

Frequent Co-Authors

Bruno Dubois
Bruno Dubois Université Paris Cité
Stefan J. Teipel
Stefan J. Teipel German Center for Neurodegenerative Diseases
Kaj Blennow
Kaj Blennow University of Gothenburg
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Arun L.W. Bokde
Arun L.W. Bokde Trinity College Dublin
Michael Ewers
Michael Ewers Ludwig-Maximilians-Universität München
Pieter Jelle Visser
Pieter Jelle Visser Amsterdam University Medical Centers
Katharina Buerger
Katharina Buerger Ludwig-Maximilians-Universität München
Philip Scheltens
Philip Scheltens Amsterdam UMC
Giovanni B. Frisoni
Giovanni B. Frisoni University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in healthcare can open doors to a variety of rewarding career paths. For registered nurses aiming to advance their qualifications, there are online rn to bsn programs no clinicals required, which provide greater flexibility by allowing students to complete their coursework without in-person practicums. This makes balancing work, life, and study much easier.

If you’re looking for a higher level of practice, Doctor of Nursing Practice (DNP) degrees can be pursued online as well. Students can consider dnp programs online that offer accelerated pathways. Some individuals seek the easy dnp programs that focus on a more streamlined curriculum, making the degree accessible for those with demanding schedules or varied experience levels.

For those interested in entering the nursing field quickly, there are also fast track lpn programs online, allowing students to start their career as a Licensed Practical Nurse in a shorter timeframe. Each option provides unique opportunities for advancement while helping you tailor your education journey to fit your professional goals and lifestyle.

Best Scientists Citing Harald Hampel

Trending Scientists